These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11410788)

  • 1. Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin.
    Funato T; Satou J; Kozawa K; Fujimaki S; Miura T; Kaku M
    Oncol Rep; 2001; 8(4):807-10. PubMed ID: 11410788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the sensitivity to cisplatin with c-myc over-expression or down-regulation in colon cancer cells.
    Funato T; Kozawa K; Kaku M; Sasaki T
    Anticancer Drugs; 2001 Nov; 12(10):829-34. PubMed ID: 11707650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
    Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
    Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
    Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G
    Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect of cationic liposome-mediated antisense c-myb oligonucleotide on the growth of glioma].
    Zhao D; You C; Huang G; Liao X; Tan H
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):19-22. PubMed ID: 12599418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense Bcl2 oligonucleotide in cisplatin-resistant bladder cancer cell lines.
    Hong JH; Lee E; Hong J; Shin YJ; Ahn H
    BJU Int; 2002 Jul; 90(1):113-7. PubMed ID: 12081782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
    Anfossi G; Gewirtz AM; Calabretta B
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3379-83. PubMed ID: 2541445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells.
    Normanno N; Tortora G; De Luca A; Pomatico G; Casamassimi A; Agrawal S; Mendelsohn J; Bianco AR; Ciardiello F
    Oncol Rep; 1999; 6(5):1105-9. PubMed ID: 10425310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
    Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
    J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of colon cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA of the Ki-ras gene.
    Sakakura C; Hagiwara A; Tsujimoto H; Ozaki K; Sakakibara T; Oyama T; Ogaki M; Imanishi T; Yamazaki J; Takahashi T
    Anticancer Drugs; 1995 Aug; 6(4):553-61. PubMed ID: 7579559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased sensitivity to cisplatin in gastric cancer by antisense inhibition of the her-2/neu (c-erbB-2) gene.
    Funato T; Kozawa K; Fujimaki S; Miura T; Kaku M
    Chemotherapy; 2001; 47(4):297-303. PubMed ID: 11399867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
    Ratajczak MZ; Kant JA; Luger SM; Hijiya N; Zhang J; Zon G; Gewirtz AM
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11823-7. PubMed ID: 1281545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: In vivo activity and mechanisms.
    Wang H; Wang S; Nan L; Yu D; Agrawal S; Zhang R
    Int J Oncol; 2002 Apr; 20(4):745-52. PubMed ID: 11894120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA uptake-stimulating protein increases the antiproliferative effect of c-myb antisense oligonucleotide on leukemic cells.
    Tóth G; Schlammadinger J; Aradi J; Antal-Szalmás P; Sipka S; Balázs M; Kovács P; Fehér Z; Falus A
    Cell Biol Int; 2004; 28(11):817-23. PubMed ID: 15563404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines.
    Thompson MA; Flegg R; Westin EH; Ramsay RG
    Oncogene; 1997 Apr; 14(14):1715-23. PubMed ID: 9135073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa.
    Ramsay RG; Thompson MA; Hayman JA; Reid G; Gonda TJ; Whitehead RH
    Cell Growth Differ; 1992 Oct; 3(10):723-30. PubMed ID: 1445802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
    Raschellà G; Negroni A; Skorski T; Pucci S; Nieborowska-Skorska M; Romeo A; Calabretta B
    Cancer Res; 1992 Aug; 52(15):4221-6. PubMed ID: 1638535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of cisplatin resistance in vivo by an anti-fos ribozyme.
    Funato T; Ishii T; Kanbe M; Scanlon KJ; Sasaki T
    In Vivo; 1997; 11(3):217-20. PubMed ID: 9239514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
    Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B
    Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.